Date: 28 April 2022
Time: 1:00 PM UTC
Duration: 60 min
Language: English
Format: Online
This webinar is over - watch on demand here

Worldwide: World IP Day - Access to Medicine, Compulsory Licensing and Protection of Patent Rights

Access to vaccine and patent rights have never been more important and debatable. This year Gün + Partners would like to celebrate World IP Day focusing on this delicate topic and sharing insights from practitioners Aysel Korkmaz Yatkin , Selin Sinem Erciyas of Gün + Partners and Camilla Balleny of Carpmaels & Ransford.  

This joyful discussion will cover the following topics:
• What really hinders the access to medicine,
• Why it is more important to support patent protection in situations like pandemic
• Compulsory licensing of patents,
• Protection of patent rights and patent enforcement in overall  
• Q&A

Selin Sinem Erciyas

Selin Sinem Erciyas joined the firm in 2006 and became a partner in 2014. She specializes in life sciences and intellectual property with a special focus on patents and utility models.

Selin has been involved in a number of advisory and litigation matters in all fields of IP and has handled hundreds of contentious and non-contentious administrative oppositions and court actions involving intellectual property rights, particularly in relation with protection of patent rights.

She regularly advises on patent infringement actions, declaration of non-infringement actions and nullity actions.

Aysel Korkmaz Yatkin

Aysel Korkmaz Yatkin joined the firm in 2008 and became a partner in 2020. She specializes in intellectual property; insurance and reinsurance; dispute management and business crimes and anti-corruption practices with a special focus on patents and utility models.

With almost 15-years of experience on patents, she has been providing consultancy on all matters related to the patent law and has been leading numerous patent actions.

With a vast advisory and litigation expertise particularly with regards to protection of patent rights, Aysel Korkmaz Yatkin also represents various pharmaceutical companies before the Ministry of Health in relation to the regulatory matters and gives support to these companies on regulatory matters during the audits conducted before the Ministry of Health.

Camilla Balleny

Camilla is a Partner at the leading European IP firm, Carpmaels & Ransford. She works exclusively in relation to in the life sciences patent matters, representing clients in the UK and on multi-jurisdictional litigation and advice.

She has a degree in genetics and having spent time in-house at a large biotech company, Camilla has a developed a very strong understanding of both the technical and commercial world in which her clients operate.

"Camilla is very thoughtful, strategic, and doesn't leave any stone unturned. She is proactive in identifying potential issues and presents them in a way that allows clients to make an informed decision."
Chambers & Partners 2021”.

FREE News Alerts
Sign Up for our free News Alerts - All the latest articles on your chosen topics condensed into a free bi-weekly email.
Popular Contributors
Upcoming Events
Mondaq Social Media